133 related articles for article (PubMed ID: 28782337)
1. Diagnosis, Management And Prevention Of Hepatitis C In Pakistan 2017.
Umar M; Khaar HT; Akhter TS; Aslam F; Ahmad SI; Asghar RM; Khurram M; Hussain T; Salamat A; Khan AA; Fazal-E-Hadi ; Minhas ZM; Shah HA; Farooqui J; Naqvi AA; Mohsin A; Waseem-Ud-Din ; Bhutta SI; Hasnain Syed SU; Qureshi S; Adam T; Uddin M; Tayyab GU; Najeeb Ul Haq ; Shoaib A; Ambreen S; Shahzad A; Ikram N; Nisar G; Khan MM; Osama M
J Ayub Med Coll Abbottabad; 2016; 28(4 Suppl 1):S839-S882. PubMed ID: 28782337
[TBL] [Abstract][Full Text] [Related]
2. NIH Consensus Statement on Management of Hepatitis C: 2002.
NIH Consens State Sci Statements; 2002 Jun 10-12; 19(3):1-46. PubMed ID: 14768714
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus prevalence and genotype distribution in Pakistan: Comprehensive review of recent data.
Umer M; Iqbal M
World J Gastroenterol; 2016 Jan; 22(4):1684-700. PubMed ID: 26819533
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C Virus and Interferon-Free Antiviral Therapeutics Revolution: Implications for Pakistan.
Afzal MS
Viral Immunol; 2017 May; 30(4):252-257. PubMed ID: 28118096
[TBL] [Abstract][Full Text] [Related]
5. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing.
Omata M; Kanda T; Wei L; Yu ML; Chuang WL; Ibrahim A; Lesmana CR; Sollano J; Kumar M; Jindal A; Sharma BC; Hamid SS; Dokmeci AK; Al-Mahtab M; McCaughan GW; Wasim J; Crawford DH; Kao JH; Yokosuka O; Lau GK; Sarin SK
Hepatol Int; 2016 Sep; 10(5):681-701. PubMed ID: 27229718
[TBL] [Abstract][Full Text] [Related]
6. KDOQI US Commentary on the 2018 KDIGO Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C.
Roth D; Bloom RD; Molnar MZ; Reese PP; Sawinski D; Sise ME; Terrault NA
Am J Kidney Dis; 2020 May; 75(5):665-683. PubMed ID: 32279907
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and Treatment of Untypable HCV Variants in Different Districts of Punjab, Pakistan.
Zafar A; Imran M; Zahoor S; Shah ZH; Ali M; Afzal MS
Viral Immunol; 2018; 31(6):426-432. PubMed ID: 29920175
[TBL] [Abstract][Full Text] [Related]
8. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population.
Yu ML; Chen PJ; Dai CY; Hu TH; Huang CF; Huang YH; Hung CH; Lin CY; Liu CH; Liu CJ; Peng CY; Lin HC; Kao JH; Chuang WL
J Formos Med Assoc; 2020 Jun; 119(6):1019-1040. PubMed ID: 32359879
[TBL] [Abstract][Full Text] [Related]
9. Closing the Gap: The Challenges of Treating Hepatitis C Virus Genotype 3 Infection.
Martin MT; Deming P
Pharmacotherapy; 2017 Jun; 37(6):735-747. PubMed ID: 28374965
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the hepatitis C virus epidemic in Pakistan.
Mahmud S; Al Kanaani Z; Abu-Raddad LJ
BMC Infect Dis; 2019 Sep; 19(1):809. PubMed ID: 31521121
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Hepatitis C Virus Genotypes in Pakistan: Current Scenario and Review of Literature.
Haqqi A; Munir R; Khalid M; Khurram M; Zaid M; Ali M; Shah ZH; Ahmed H; Afzal MS
Viral Immunol; 2019 Nov; 32(9):402-413. PubMed ID: 31556811
[TBL] [Abstract][Full Text] [Related]
12. Diagnostically untypable hepatitis C virus variants: it is time to resolve the problem.
Afzal MS; Khan MY; Ammar M; Anjum S; Zaidi NU
World J Gastroenterol; 2014 Dec; 20(46):17690-2. PubMed ID: 25516688
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C elimination in Pakistan is a distant dream unless government controls the health sector.
Altaf A; Pasha SK
J Pak Med Assoc; 2020 Dec; 70(12(B)):2454-2456. PubMed ID: 33475562
[TBL] [Abstract][Full Text] [Related]
14. Screening, diagnosis, treatment, and management of hepatitis C: a novel, comprehensive, online resource center for primary care providers and specialists.
Lebovics E; Czobor K
Am J Med; 2014 Nov; 127(11):e11-e14. PubMed ID: 25308624
[TBL] [Abstract][Full Text] [Related]
15. Consensus guidelines for the management of hepatitis C infection.
Consensus Guidelines Committee for the Management of Hepatitis C Infection
Saudi Med J; 2003 Jul; 24 Suppl 2():S99-118. PubMed ID: 25121186
[TBL] [Abstract][Full Text] [Related]
16. PSG consensus statement on management of hepatitis C virus infection--2003.
Hamid S; Umar M; Alam A; Siddiqui A; Qureshi H; Butt J;
J Pak Med Assoc; 2004 Mar; 54(3):146-50. PubMed ID: 15129876
[No Abstract] [Full Text] [Related]
17. An evidence of high prevalence of Hepatitis C virus in Faisalabad, Pakistan.
Ahmad N; Asgher M; Shafique M; Qureshi JA
Saudi Med J; 2007 Mar; 28(3):390-5. PubMed ID: 17334466
[TBL] [Abstract][Full Text] [Related]
18. Recurrence of hepatitis C virus after treatment with pegylated interferon and direct acting antivirals in Punjab Pakistan.
Raza MN; Sughra K; Zeeshan N; Anwar MZ; Shahzad MA; Rashid U; Afroz A; Munir H
Braz J Biol; 2021; 83():e252610. PubMed ID: 34909837
[TBL] [Abstract][Full Text] [Related]
19. A case of a patient infected with a hepatitis C virus genotype 3a multidrug resistant variant in Pakistan.
Zia A; Ali M; Aziz H; Zia M; Shinwari ZK; Raza A
Infect Dis Poverty; 2018 Feb; 7(1):11. PubMed ID: 29429413
[TBL] [Abstract][Full Text] [Related]
20. [Hungarian consensus guideline for the diagnosis and treatment of B, C, and D viral hepatitis].
Makara M; Horváth G; Gervain J; Pár A; Szalay F; Telegdy L; Tornai I; Ujhelyi E; Hunyady B
Orv Hetil; 2012 Mar; 153(10):375-94. PubMed ID: 22370225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
